Mortality in Elderly Patients Taking Furosemide: Prospective Cohorts Study

Table 3

Relationship between drug exposure and mortality at 5 years (univariate analysis).

	Deceased exposed	Deceased not exposed	Odds ratio	95% CI
ACE inhibitors	56 (41%)	170 (31%)	1.52	1.02–2.26	0.042
ARB	39 (30%)	187 (34%)	0.87	0.56–1.33	0.533
Beta-blockers	22 (30%)	204 (33%)	0.87	0.50–1.48	0.693
Calcium antagonists	32 (30%)	194 (33%)	0.88	0.55–1.34	0.652
Alpha-blockers	17 (44%)	209 (32%)	1.62	0.84–3.15	0.199
Nitrites	20 (61%)	206 (32%)	3.33	1.63–7.14	0.001
Diuretics	86 (45%)	140 (28%)	2.04	1.43–2.93	0.001
Torasemide	21 (41%)	205 (32%)	1.47	0.79–2.69	0.216
Spironolacton	13 (54%)	213 (32%)	2.49	1.09–6.00	0.044
Chlorthalidone	1 (11%)	225 (33%)	0.25	0.01–1.63	0.283
Hydrochlorothiazide	18 (38%)	208 (33%)	1.24	0.65–2.31	0.525
Indapamide	4 (31%)	222 (33%)	0.90	0.26–2.89	1.000
Amiloride	6 (46%)	220 (33%)	1.76	0.58–5.79	0.373
Furosemide	38 (68%)	188 (30%)	4.95	2.77–9.09	<0.001